Boc-Asp-OHCAS# 13726-67-5 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 13726-67-5 | SDF | Download SDF |
PubChem ID | 302432 | Appearance | Powder |
Formula | C9H15NO6 | M.Wt | 233.22 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 2-[(2-methylpropan-2-yl)oxycarbonylamino]butanedioic acid | ||
SMILES | CC(C)(C)OC(=O)NC(CC(=O)O)C(=O)O | ||
Standard InChIKey | KAJBMCZQVSQJDE-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C9H15NO6/c1-9(2,3)16-8(15)10-5(7(13)14)4-6(11)12/h5H,4H2,1-3H3,(H,10,15)(H,11,12)(H,13,14) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Boc-Asp-OH Dilution Calculator
Boc-Asp-OH Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 4.2878 mL | 21.439 mL | 42.878 mL | 85.7559 mL | 107.1949 mL |
5 mM | 0.8576 mL | 4.2878 mL | 8.5756 mL | 17.1512 mL | 21.439 mL |
10 mM | 0.4288 mL | 2.1439 mL | 4.2878 mL | 8.5756 mL | 10.7195 mL |
50 mM | 0.0858 mL | 0.4288 mL | 0.8576 mL | 1.7151 mL | 2.1439 mL |
100 mM | 0.0429 mL | 0.2144 mL | 0.4288 mL | 0.8576 mL | 1.0719 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Boc-Asp-OH
- Chlorantholide E
Catalog No.:BCN4836
CAS No.:1372558-36-5
- Chlorantholide C
Catalog No.:BCN4837
CAS No.:1372558-35-4
- Chlorantholide B
Catalog No.:BCN4834
CAS No.:1372558-34-3
- Chlorantholide A
Catalog No.:BCN4835
CAS No.:1372558-33-2
- GSK2636771
Catalog No.:BCC4993
CAS No.:1372540-25-4
- Dodoviscin J
Catalog No.:BCN3945
CAS No.:1372527-42-8
- Dodoviscin I
Catalog No.:BCN3926
CAS No.:1372527-40-6
- Dodoviscin H
Catalog No.:BCN3918
CAS No.:1372527-39-3
- Dodoviscin A
Catalog No.:BCN3927
CAS No.:1372527-25-7
- Voriconazole
Catalog No.:BCC2275
CAS No.:137234-62-9
- Sodium Orthovanadate
Catalog No.:BCC3856
CAS No.:13721-39-6
- Spinorphin
Catalog No.:BCC2349
CAS No.:137201-62-8
- Boc-Hyp-OH
Catalog No.:BCC3251
CAS No.:13726-69-7
- Boc-Glu(OtBu)-OH
Catalog No.:BCC3392
CAS No.:13726-84-6
- Boc-Gln-OH
Catalog No.:BCC3382
CAS No.:13726-85-7
- Pemetrexed
Catalog No.:BCC9115
CAS No.:137281-23-3
- 4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pymol[2,3-d]pyrimodin-5-yl)ethyl]benzoic acid
Catalog No.:BCC8670
CAS No.:137281-39-1
- 4,5-Dioxo-4,5-seco-11(13)-cadinen-12-oic acid
Catalog No.:BCN1577
CAS No.:137288-61-0
- Dehydroeffusol
Catalog No.:BCN2927
CAS No.:137319-34-7
- Cathepsin S inhibitor
Catalog No.:BCC1455
CAS No.:1373215-15-6
- LY 215840
Catalog No.:BCC7101
CAS No.:137328-52-0
- Thrombin Receptor Agonist Peptide
Catalog No.:BCC3950
CAS No.:137339-65-2
- Boc-Lys-OH
Catalog No.:BCC3410
CAS No.:13734-28-6
- Boc-Phe-OH
Catalog No.:BCC3432
CAS No.:13734-34-4
[Hydrolysis of primary amide groups in Asn/Gln-containing peptides].[Pubmed:10923187]
Bioorg Khim. 2000 Jun;26(6):403-10.
Peptides Boc-Ala-Asn/Gln-OH and Boc-Asn/Gln-Ala-OH were saponified with barium hydroxide to corresponding Asp/Glu-containing peptides. Under the conditions of saponification, Boc-Asn-Ala-OH additionally afforded Boc-Asp-OH, isopeptide Boc-Asp(Ala)-OH, and Boc-NHSuc > Ala-OH, with the third being the key intermediate in these transformations. Boc-Asp(OMe)-Ala-OMe underwent similar transformations under treatment with diazomethane or triethylamine. Saponification with barium hydroxide was accompanied by a high epimerization of N-terminal amino acid residues, whereas the products of the diazomethane treatment of Boc-Asp(OMe)-Ala-OMe had a low degree of epimerization.